TPO and polycystic ovary syndrome: Patients who received thyroid hormone supplementation for initial TSH levels > 2.5 μIU/ml achieved pregnancy and revealed increased TPO-Ab and TG-Ab levels as well as polycystic ovary syndrome significantly more often (see Table 3).